Search Results 2041-2050 of 10527 for Lupus
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy.
Translational Neuroimmunology Laboratory of Charles L. Howe, Ph.D., at Mayo Clinic: Researches novel neuroprotective strategies for the nervous system.
About this study. Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 30% of the patients with the ...
It is very different from addiction, which is drastic behavior an individual exhibits to obtain opioids, such as stealing medications, buying street drugs to ...
Aristizabal MA, Sluzevich JC, Singer E. Pruritic eruption associated with rheumatoid arthritis: rheumatoid neutrophilic dermatitis. BMJ Case Rep.
The purpose of this study is to establish an opioid and multiple addiction (OMA) biobank that creates a comprehensive standard patient phenotype using ...
The purpose of this research is to study the natural history of "ventilator associated pneumonia" and its causes and treatments. Participation eligibility.
The purpose of this study is to evaluate the effectiveness of Lu AF82422 on disease progression in patients with Multiple System Atrophy (MSA). Participation ...
Zamora AC, Wesselius LJ, Gotway MB, Tazelaar HD, Diaz-Arumir A, Nagaraja V. Diagnostic Approach to Interstitial Lung Diseases Associated with Connective ...
The purpose of this study is to evaluate whether prolonged oral levosimendan can preserve respiratory function more effectively than placebo, resulting in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your Annual Fund gift can drive advancements in cancer care.